Search by Drug Name or NDC
NDC 00990-7115-09 Potassium Chloride in Sodium Chloride 1.49; 9 g/1000mL; g/1000mL Details
Potassium Chloride in Sodium Chloride 1.49; 9 g/1000mL; g/1000mL
Potassium Chloride in Sodium Chloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ICU Medical Inc.. The primary component is POTASSIUM CHLORIDE; SODIUM CHLORIDE.
Product Information
NDC | 00990-7115 |
---|---|
Product ID | 0990-7115_5b28bce5-609f-4e23-8d0f-0cbd2ada8ddf |
Associated GPIs | 79992002102020 |
GCN Sequence Number | 001198 |
GCN Sequence Number Description | potassium chloride in 0.9%NaCl IV SOLN 20 MEQ/L INTRAVEN |
HIC3 | C1D |
HIC3 Description | POTASSIUM REPLACEMENT |
GCN | 56590 |
HICL Sequence Number | 014772 |
HICL Sequence Number Description | POTASSIUM CHLORIDE IN 0.9 % SODIUM CHLORIDE |
Brand/Generic | Generic |
Proprietary Name | Potassium Chloride in Sodium Chloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | SODIUM CHLORIDE and POTASSIUM CHLORIDE |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 1.49; 9 |
Active Ingredient Units | g/1000mL; g/1000mL |
Substance Name | POTASSIUM CHLORIDE; SODIUM CHLORIDE |
Labeler Name | ICU Medical Inc. |
Pharmaceutical Class | Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA019686 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00990-7115-09 (00990711509)
NDC Package Code | 0990-7115-09 |
---|---|
Billing NDC | 00990711509 |
Package | 12 POUCH in 1 CASE (0990-7115-09) / 1 BAG in 1 POUCH / 1000 mL in 1 BAG |
Marketing Start Date | 2019-11-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |